The real-life findings showed that treatment with brodalumab improved health-related quality of life (HRQOL) for patients but itching prevented complete improvement. Despite achieving clear or almost ...

Medically reviewed by Casey Gallagher, MD Key Takeaways Changes in body temperature and hormones at night can make your scalp itch more.Common skin conditions that cause nighttime scalp itching ...

Higher disease acceptance in patients with psoriasis is linked to better outcomes, underscoring the need for psychological resilience in treatment. The study found illness acceptance negatively ...

Please provide your email address to receive an email when new articles are posted on . BOSTON — Improvement in plaque psoriasis itch and severity, including in intertriginous areas, was significant ...

A team of Harvard researchers has identified a promising new approach for treating psoriasis — a topical lotion containing nucleic acids that transiently disrupt inflammatory gene activity. This ionic ...

Please provide your email address to receive an email when new articles are posted on . Patient reported data from two phase 3 trials found roflumilast cream 0.3% significantly reduced itch severity ...

DENVER — The topical TrkA kinase inhibitor CT327 reduces chronic itch in patients with psoriasis, according to results from a new study. "This is an unmet need," said Gil Yosipovitch, MD, professor of ...

More than eight million people in the United States have the autoimmune skin condition known as psoriasis, according to the National Psoriasis Foundation. Psoriasis is a chronic condition. There’s no ...

If you’ve ever experienced an itchy scalp, you’ll know how uncomfortable and downright annoying it can be. Whether you have a scalp condition like psoriasis or just experience a bit of itching here ...

A phase 3 trial shows that apremilast, an oral phosphodiesterase 4 inhibitor, improves symptoms, disease severity, and ...

Back in October, the 2025 Fall Clinical Dermatology Conference showcased some of the most exciting advances in skin disease treatment this year. From pill-based TYK2 inhibitors and durable IL-23 ...